Tenofovir-d6 (CAS 1020719-94-1)

Tenofovir-d6 is a deuterated version of tenofovir, where six hydrogen atoms are replaced by deuterium. This modification is used extensively in research to enhance the understanding of tenofovir′s metabolic and kinetic profiles through various analytical techniques. The primary mechanism of action of tenofovir, and thus tenofovir-d6, involves its activity as a nucleotide analog reverse transcriptase inhibitor (NtRTI). Tenofovir is an analog of adenosine 5′-monophosphate, and once phosphorylated in the cell, the active form, tenofovir diphosphate, competes with natural deoxyadenosine 5′-triphosphate (dATP) for incorporation into the viral DNA by HIV reverse transcriptase. Upon incorporation, tenofovir causes chain termination due to the lack of a 3′-OH group necessary for the formation of the phosphodiester bond with the next nucleotide. This stops the replication of the viral genome, effectively inhibiting viral proliferation. In research, tenofovir-d6 is primarily used in mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy. The incorporation of deuterium atoms improves the detection sensitivity and resolution in these techniques, making tenofovir-d6 a valuable tool for detailed kinetic studies. Researchers use this deuterated compound to trace the absorption, distribution, metabolism, and excretion of tenofovir more accurately, as the deuterium atoms reduce the background noise and increase the precision of quantitative measurements. Furthermore, tenofovir-d6 is utilized in studies exploring the enzymatic processes involved in the activation and metabolism of tenofovir. By comparing the pathways of tenofovir and tenofovir-d6, scientists can identify the specific enzymes and cofactors involved in converting tenofovir into its active diphosphate form and subsequently understand how different biological factors might affect its activity.